CMML facts Flashcards
Somatic mutations in CMML- prognosis
TET2- good
ASXL1 DNMT3A, RUNX1, RAS, SRSF2- poor
Proliferative vs dysplastic CMML
13K WBC
CMML1
<5% PB blasts
<10% BM blasts
CMML2
5-19% PB blasts
10-19 BM blasts
CMML monocyte phnotype
CD14+/CD16- (classical) >94%
in reactive monocytosis CD16+ monocytes are common
importance of clonal plasmocytic dendritic cells in CMML BMB
30% of biopsies
risk for developing AML
Clonal cytogentic changes in CMML %
20-30%
Common cytogenetic alterations in CMML
trisomy 8
-Y
del 7
trisomy 21
complex
poor risk cytogenetics in CMML
trisomy 8, del 7, complex
Autoimmune diseases in CMML %
20-30%
favorable risk cytogenetics in CMML
-Y, normal
Which test is important in CMML pts with AI
UBA1
to check for vexas
mutations in correlation to autoimmune diseases in CMML
TET2
SRSF2
IDH
Presence of renal disease in CMML
35% AKI
7% CKD
can be due to lysozyme renal toxicity- nictitating HMA Tx
CMML monocyte count diagnostic criteria
500
and 10%